June 18, 2025

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Read more

Together,
we can reach
higher ground.

At Climb Bio, we believe elevating relationships leads to more meaningful insights, better answers, and ultimately, to more inspired medicines for patients living with immune-mediated diseases.

June 18, 2025

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Read more

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam nisl ex, aliquam quis nisl ultricies, tincidunt condimentum mauris. Donec venenatis imperdiet velit ullamcorper convallis. Suspendisse a eleifend lorem. Phasellus maximus sit amet felis a malesuada.

Scientific Approach

We develop differentiated, best-in-class monoclonalantibodies for immune-mediated diseases.

Pipeline

We have the potential to address numerous immune-mediated diseases that impact large patient populations with limited therapeutic options.

Clinical Trials

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam nisl ex, aliquam quis nisl ultricies,
tincidunt condimentum mauris.

Patient Stories

We all only have one life to live. At Climb, we all feel the urgency to give everyone living with an autoimmune disease more quality time—and less time thinking of themselves as a patient.

Learn more

Come climb with us

Here you’ll find good people. Smart people. Curious people. Our team has a diversified past, a singular focus on the now, and an unshakeable commitment to a better future.

Open Positions